Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A.

scientific article

Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/GUT.2003.026260
P932PMC publication ID1773968
P698PubMed publication ID14960524
P5875ResearchGate publication ID8694270

P2093author name stringC F Dietrich
A Ignee
J Trojan
G Schuessler
C Fellbaum
P2860cites workBacillary angiomatosis of the liver, a suspected ultrasound diagnosis?Q40612353
Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C.Q42984210
Sonographic findings of the hepatobiliary-pancreatic system in adult patients with cystic fibrosisQ43947962
Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imagingQ67973184
Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumorsQ69359315
Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter studyQ73155172
Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastasesQ73535910
Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastasesQ73781851
Contrast enhanced power Doppler sonography: comparison of various administration forms of the ultrasound contrast agent LevovistQ73941077
B-mode enhancement at phase-inversion US with air-based microbubble contrast agent: initial experience in humansQ73972012
Stimulated acoustic emission in liver parenchyma with LevovistQ74282334
Multiple adenomas and hepatocellular carcinoma in a renal transplant patient with glycogen storage disease type 1a (von Gierke disease)Q74286389
Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experienceQ74433405
Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis CQ77051786
Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experienceQ77337291
Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liverQ78397096
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)401-405
P577publication date2004-03-01
P1433published inGutQ5621669
P1476titleImproved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A.
P478volume53

Reverse relations

cites work (P2860)
Q53357444A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma.
Q26860623Alcohol and hepatocellular carcinoma: a review and a point of view
Q36980220Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography
Q30433022Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI
Q28084620Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearances
Q26801185Benign liver tumors in pediatric patients - Review with emphasis on imaging features.
Q52941050Characterization of hyperechoic focal liver lesions: quantitative evaluation with pulse inversion harmonic imaging in the late phase of levovist.
Q93059908Combination of CEUS and MRI for the diagnosis of periampullary space-occupying lesions: a retrospective analysis
Q50543212Contrast enhanced ultrasound features of hepatic cystadenoma and hepatic cystadenocarcinoma.
Q30478161Contrast enhanced ultrasound of renal masses
Q38083837Contrast-Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis
Q47391871Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis
Q30361965Contrast-enhanced endobronchial ultrasound: Potential value of a new method.
Q33788129Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer
Q53583559Contrast-enhanced ultrasonography in hepatic angiomyolipoma.
Q51648265Contrast-enhanced ultrasonography with SonoVue: differentiation between benign and malignant lesions of the spleen.
Q30421027Contrast-enhanced ultrasonography: advance and current status in abdominal imaging.
Q30455788Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases
Q36909256Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma.
Q53484750Contrast-enhanced ultrasound of histologically proven liver hemangiomas.
Q30455431Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions
Q30488974Current role of ultrasound for the management of hepatocellular carcinoma
Q30478166Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound
Q53576054Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound.
Q26851954Fortuitously discovered liver lesions
Q97881581Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS
Q34604513Guidelines for contrast enhanced ultrasound (CEUS)--update 2008
Q41126839Hepatic malignancies: Correlation between sonographic findings and pathological features
Q83286864Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules
Q49165838How to perform Contrast-Enhanced Ultrasound (CEUS).
Q63351040Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound
Q51050880Improvement in the routine diagnostic assessment of the liver by high-resolution sonography: an analysis of 999 cases.
Q51719692Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma.
Q52990527Liver Contrast-Enhanced Ultrasound Improves Detection of Liver Metastases in Patients with Pancreatic or Periampullary Cancer.
Q36332207Pictorial review: sonographic patterns of diffuse and focal fatty infiltration of the liver: differential diagnosis to metastatic liver disease
Q30433373Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography
Q38082982Radiofrequency ablation of liver metastases from colorectal cancer: a literature review
Q36579630Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma
Q53362427Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index.
Q36778695Technology insight: advances in liver imaging
Q38922933Temporal regularization of ultrasound-based liver motion estimation for image-guided radiation therapy
Q44021980Terminology for contrast-enhanced sonography: a practical glossary
Q58618414Ultrasound Imaging of Hepatocellular Adenoma Using the New Histology Classification
Q28077669Ultrasound contrast agents
Q30465459Vascularisation pattern of chronic pancreatitis compared with pancreatic carcinoma: results from contrast-enhanced endoscopic ultrasound
Q53566652[Guidelines for the use of contrast agents in ultrasound]